<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29129316</article-id>
<article-id pub-id-type="pmc">5812918</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(17)30393-2</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2017.09.024</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Consequences of <italic>CHRNA7</italic> Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gillentine</surname>
<given-names>Madelyn A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Jiani</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bajic</surname>
<given-names>Aleksandar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cummock</surname>
<given-names>Steven</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jean J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaaf</surname>
<given-names>Christian P.</given-names>
</name>
<email>schaaf@bcm.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="aff2"><label>2</label>Jan and Dan Neurological Research Institute, Houston, TX 77030, USA</aff>
<aff id="aff3"><label>3</label>Department of Molecular and Cellular Biology, Stem Cells and Regenerative Medicine Center, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="aff4"><label>4</label>Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="aff5"><label>5</label>Human Stem Cell Core, Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>schaaf@bcm.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>07</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>101</volume>
<issue>6</issue>
<fpage>874</fpage>
<lpage>887</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 American Society of Human Genetics.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American Society of Human Genetics</copyright-holder>
</permissions>
<abstract id="abs0010">
<p>Copy-number variants (CNVs) of chromosome 15q13.3 manifest clinically as neuropsychiatric disorders with variable expressivity. <italic>CHRNA7</italic>, encoding for the α7 nicotinic acetylcholine receptor (nAChR), has been suggested as a candidate gene for the phenotypes observed. Here, we used induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs) derived from individuals with heterozygous 15q13.3 deletions and heterozygous 15q13.3 duplications to investigate the <italic>CHRNA7-</italic>dependent molecular consequences of the respective CNVs. Unexpectedly, both deletions and duplications lead to decreased α7 nAChR-associated calcium flux. For deletions, this decrease in α7 nAChR-dependent calcium flux is expected due to haploinsufficiency of <italic>CHRNA7</italic>. For duplications, we found that increased expression of <italic>CHRNA7</italic> mRNA is associated with higher expression of nAChR-specific and resident ER chaperones, indicating increased ER stress. This is likely a consequence of inefficient chaperoning and accumulation of α7 subunits in the ER, as opposed to being incorporated into functional α7 nAChRs at the cell membrane. Here, we showed that α7 nAChR-dependent calcium signal cascades are downregulated in both 15q13.3 deletion and duplication NPCs. While it may seem surprising that genomic changes in opposite direction have consequences on downstream pathways that are in similar direction, it aligns with clinical data, which suggest that both individuals with deletions and duplications of 15q13.3 manifest neuropsychiatric disease and cognitive deficits.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>iPSCs</kwd>
<kwd>NPCs</kwd>
<kwd>CHRNA7</kwd>
<kwd>15q13.3 CNVs</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>neuropsychiatric disorders</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: November 9, 2017</p>
</notes>
</front>
</article>
</pmc-articleset>